Magnesium and Schizophrenia: What’s the Connection?

The connection between magnesium and schizophrenia sits at the intersection of genetics, brain chemistry, and nutrition, but the evidence is genuinely messy. Some studies find lower magnesium in people with schizophrenia, others find normal levels, and a few have even reported elevated levels. What makes the relationship worth exploring is not any single blood test result but a convergence of clues from genome studies, cellular biology, and medication effects that keeps pulling researchers back to this mineral.

Blood Magnesium Levels Tell a Confusing Story

If you measured magnesium in the blood of people with schizophrenia and compared them to people without the disorder, you might expect a clear answer. You would not get one. The research is split in a way that turns out to be instructive, because the disagreement reveals something important about how magnesium behaves in the body.

A cross-sectional study from a tertiary hospital in eastern India found that serum magnesium was significantly lower in patients with schizophrenia compared to healthy controls, and that the reduction tracked with illness severity.¹ An older study comparing plasma magnesium across several psychiatric conditions found that people with schizophrenia and depression had lower levels than healthy controls.²

But a meta-analysis of first-episode psychosis studies, pooling data from several hundred participants, found no significant differences in blood levels of any dietary mineral, including magnesium, between people experiencing their first psychotic episode and healthy controls.³ A study comparing early-onset and chronic schizophrenia patients to controls reported essentially identical serum magnesium across all three groups.⁴

Part of the confusion comes from where you look. One study measured magnesium inside red blood cells rather than just floating in plasma. It found a dramatic drop in the intracellular measurement — even though plasma levels looked normal.⁵ This matters because most of the body’s magnesium sits inside cells, not in the bloodstream. A standard blood panel measures the roughly 1% of total magnesium that circulates in plasma. If the problem involves magnesium getting into cells rather than magnesium being absent from the body, plasma levels could look perfectly fine while something is genuinely wrong at the cellular level.

A 2020 systematic review drove the point home by highlighting how contradictory the literature is: one included study reported that patients with schizophrenia actually had increased plasma magnesium, while another found no differences at all in drug-free patients.⁶ The honest read of this evidence is that schizophrenia probably doesn’t produce a simple, reliable magnesium deficiency you can pick up on routine blood work. The relationship, if it exists, is more subtle.

A Genetic Thread Through CNNM2

The strongest piece of evidence linking magnesium to schizophrenia doesn’t come from blood tests. It comes from genetics. Large genome-wide association studies have repeatedly flagged a region on chromosome 10 as a schizophrenia risk locus. Within that region sits a gene called CNNM2, which encodes a protein involved in magnesium transport.⁷

The finding isn’t just that the gene happens to sit near a risk variant. Functional analyses have shown that lower expression of CNNM2 is significantly associated with schizophrenia, and two independent risk variants in the region both point toward reduced CNNM2 activity.⁸ The gene is highly expressed in human neurons, and in animal models, reducing its expression affects sensorimotor gating (a process often disrupted in schizophrenia), cognition, and the shape of dendritic spines — the tiny protrusions on nerve cells where synaptic connections form.⁷

This is a fundamentally different kind of evidence than measuring blood levels. It suggests that some people who develop schizophrenia may have a genetically encoded weakness in how their neurons handle magnesium, regardless of whether they are eating enough magnesium-rich foods. It’s a cellular machinery problem, not necessarily a dietary one.

Magnesium’s Role in Brain Signaling

Magnesium touches several neurotransmitter systems implicated in schizophrenia. It acts as a natural blocker of NMDA receptors, which are part of the glutamate signaling system. The “glutamate hypothesis” of schizophrenia proposes that underactive NMDA receptors contribute to symptoms, which creates an obvious question about whether magnesium’s role matters here. At resting conditions, magnesium physically plugs the NMDA receptor channel. When a neuron is sufficiently activated, the plug pops out and the channel opens. How disruptions in magnesium availability would change that process in ways relevant to psychosis is still being investigated.⁹

Beyond NMDA receptors, magnesium is involved in GABAergic, dopaminergic, and serotonergic pathways. It also intersects with neuroinflammation, oxidative stress, and the production of brain-derived neurotrophic factor (BDNF), a protein crucial for nerve cell survival and growth.¹⁰ Schizophrenia involves disturbances in many of these systems simultaneously, so magnesium sits at a biological crossroads. That said, sitting at a crossroads is not the same as causing the traffic jam. Magnesium is essential for hundreds of enzymatic reactions throughout the body; the fact that it touches pathways relevant to schizophrenia doesn’t by itself prove it plays a causal role in the illness.

What the Brain Itself Shows

Most studies measure magnesium in the blood, but the brain is separated from the bloodstream by the blood-brain barrier, so blood levels don’t necessarily reflect what is happening inside the brain. A few studies have tried to look directly.

One used phosphorus magnetic resonance spectroscopy to estimate magnesium ion concentrations in the brains of people experiencing their first episode of psychosis. The result was unexciting in the best possible way: brain magnesium concentrations were not significantly different between the first-episode psychosis group and healthy controls.¹¹ The study was small and measured only one brain region at a single point in time, so it doesn’t close the question. But it reinforces the idea that whatever connection exists between magnesium and schizophrenia, it is not as simple as “patients have depleted brain magnesium.”

Poor Diet Compounds the Problem

People living with schizophrenia tend to have worse nutritional intake than the general population. A study examining eating and nutritional habits in patients with schizophrenia found lower levels of several vitamins and minerals, including magnesium.¹²

The reasons are practical and familiar to anyone who works in mental health. Antipsychotic medications can increase appetite while making people more sedentary, encouraging diets heavy in processed convenience foods that are low in magnesium-rich items like leafy greens, nuts, and whole grains. Negative symptoms of schizophrenia — reduced motivation, social withdrawal, diminished ability to plan — make grocery shopping and cooking harder. Poverty, which disproportionately affects people with serious mental illness, limits food choices further.

This creates a feedback loop that is difficult to untangle. Are lower magnesium levels a consequence of the illness and its treatment, or do they contribute to the illness? The genetic evidence through CNNM2 suggests the relationship may run in both directions, with some vulnerability built into the biology and lifestyle factors piling on top.

How Antipsychotic Medications Shift Magnesium

Antipsychotic drugs don’t just treat symptoms. They also change the body’s mineral balance. A systematic review noted that haloperidol reduced plasma magnesium levels in patients with schizophrenia, while both haloperidol and risperidone increased magnesium inside red blood cells.⁶

That pattern — plasma levels going down while intracellular levels go up — suggests the medications may be pushing magnesium from the bloodstream into cells. Whether this shift is therapeutic, incidental, or potentially harmful isn’t clear. But it means that a magnesium level measured in a treated patient reflects both the disease and the medication, making already contradictory data even harder to interpret.

On the safety side, some antipsychotics can prolong the QT interval on an electrocardiogram, which in rare cases triggers dangerous heart rhythms. At least one case report described a patient whose antipsychotic-induced QT prolongation normalized after treatment with oral magnesium sulfate.¹³ Magnesium is well established as a treatment for certain cardiac arrhythmias generally, so this application isn’t specific to psychiatry, but it highlights a clinically relevant intersection between the mineral and the medications patients take every day.

The Supplementation Question

Given the various threads connecting magnesium to schizophrenia, you might expect a robust body of supplementation trials. There isn’t one. The 2020 systematic review looking at magnesium across mental disorders found essentially one study relevant to schizophrenia, and its findings were ambiguous.⁶ The evidence base for magnesium supplementation in schizophrenia is thin almost to the point of nonexistence.

One recent trial compared quetiapine alone versus quetiapine combined with magnesium valproate. After eight weeks, the combination group showed higher scores on a standard cognitive assessment and higher serum BDNF levels.¹⁴ But magnesium valproate is fundamentally a mood-stabilizing and anticonvulsant medication. Valproate is the active pharmacological ingredient; the magnesium component is the counterion that forms the salt. Crediting any improvement to magnesium itself, rather than to the addition of a second psychiatric drug, would be a stretch the data can’t support.

Researchers have called for properly designed supplementation trials, and the mechanistic groundwork suggests they could be worthwhile.⁹ But as of now, no one has run a large, controlled trial asking whether giving supplemental magnesium to people with schizophrenia improves psychotic symptoms, cognitive function, or quality of life. The gap between interesting mechanistic data and actual clinical evidence is wide.

Not All Magnesium Reaches the Brain

For anyone thinking about supplements, there’s an additional wrinkle. Not all forms of magnesium cross the blood-brain barrier effectively. In a mouse study, magnesium sulfate — one of the most common forms — failed to raise magnesium levels in cerebrospinal fluid. Magnesium-L-threonate, a newer formulation, succeeded.¹⁵

That study was conducted in a Parkinson’s disease model, not a schizophrenia one, but the principle holds: even if brain magnesium turned out to be therapeutically relevant in psychosis, the form of the supplement would matter. Standard magnesium oxide or citrate pills, the most widely available types, may not move the needle in the central nervous system. This entire question — which forms reach the brain, at what doses, and whether that changes anything clinically — remains open.

Compulsive Water Drinking and Mineral Washout

A less well-known connection between schizophrenia and mineral balance involves compulsive water drinking, known as psychogenic polydipsia, which affects a meaningful subset of people with chronic schizophrenia. A systematic review found that roughly 45% of patients with polydipsia had dangerously low sodium.¹⁶ While sodium gets the most clinical attention, magnesium and other electrolytes can be diluted as well when large volumes of water flush minerals from the body.

Polydipsia is a reminder that the relationship between schizophrenia and mineral imbalances can be driven by behavioral symptoms of the illness, not just by some underlying neurobiological mechanism. When you see a study showing low magnesium in people with schizophrenia, you have to wonder how much is driven by patients who drink excessive water, eat poorly, or take medications that shift mineral balance — versus how much reflects something fundamental about the disease itself.

How Schizophrenia Compares to Other Psychiatric Conditions

Magnesium disruption is not unique to schizophrenia. The eastern India study that found low magnesium in schizophrenia found the same pattern in depression and obsessive-compulsive disorder.¹ A review of magnesium and zinc in schizophrenia emphasized that the same pathways — neuroinflammation, oxidative stress, BDNF — are disrupted across multiple psychiatric diagnoses.¹⁰

The picture gets more complicated when you look at mood disorders specifically. One older study found that schizophrenic and depressed patients both had lower plasma magnesium than controls, while patients with mania and Alzheimer’s disease had normal levels.² Another found that serum magnesium was actually elevated during the depressive phase of bipolar disorder.¹⁷ The pattern isn’t consistent across psychiatric conditions, which argues against a unified “magnesium deficit causes mental illness” theory and in favor of something more nuanced — magnesium probably matters in different ways for different disorders, intersecting with condition-specific pathology rather than driving any one of them on its own.

1
Journal of the Epidemiology Foundation of India. Serum Magnesium level and severity of Schizophrenia, Depression, Obsessive Compulsive Disorder: A cross Sectional and Hospital Based Study in a Tertiary Care Hospital in Eastern India
2
PubMed. Magnesium, schizophrenia and manic-depressive disease
3
Schizophrenia Bulletin. Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis
4
PubMed Central. Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
5
PubMed. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia
6
PubMed Central. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review – Section: 3.2.3. Schizophrenia
7
PubMed Central. Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia
8
PubMed. CNNM2 in schizophrenia: multilevel evidence of genetic susceptibility, magnesium homeostasis, neurodevelopment and cognitive dysfunction
9
Pharmacological Reports. Magnesium in schizophrenia
10
PubMed Central. Magnesium and Zinc in Schizophrenia
11
Schizophrenia Bulletin Open. Abnormal Brain Bioenergetics in First-Episode Psychosis
12
Revista de Psiquiatría y Salud Mental (English Edition). Eating and nutritional habits in patients with schizophrenia
13
PubMed. Antipsychotic induced prolongation of QTc interval treated with magnesium
14
PubMed Central. Therapeutic efficacy of quetiapine combined with magnesium valproate in schizophrenia: Impact on serum BDNF and GFAP levels
15
PubMed Central. Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
16
Open Journal of Psychiatry. Primary Polydipsia and sIDH Type D Due to Water-Electrolytic Disturbance in a Schizophrenic Patient: A Case Report and Systematic Review
17
PubMed. Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia–relationship to hemispheric dominance